Abstract:Smoking is a major risk factor for a variety of diseases, including cancer and immune-mediated inflammatory diseases. Tobacco smoke contains a mixture of chemicals, including a host of reactive oxygen- and nitrogen species (ROS and RNS), among others, that can damage cellular and sub-cellular targets, such as lipids, proteins, and nucleic acids. A growing body of evidence supports a key role for smoking-induced ROS and the resulting oxidative stress in inflammation and carcinogenesis. This comprehensive and up-to-date review covers four interrelated topics, including 'smoking', 'oxidative stress', 'inflammation', and 'cancer'. The review discusses each of the four topics, while exploring the intersections among the topics by highlighting the macromolecular damage attributable to ROS. Specifically, oxidative damage to macromolecular targets, such as lipid peroxidation, post-translational modification of proteins, and DNA adduction, as well as enzymatic and non-enzymatic antioxidant defense mechanisms, and the multi-faceted repair pathways of oxidized lesions are described. Also discussed are the biological consequences of oxidative damage to macromolecules if they evade the defense mechanisms and/or are not repaired properly or in time. Emphasis is placed on the genetic- and epigenetic alterations that may lead to transcriptional deregulation of functionally-important genes and disruption of regulatory elements. Smoking-associated oxidative stress also activates the inflammatory response pathway, which triggers a cascade of events of which ROS production is an initial yet indispensable step. The release of ROS at the site of damage and inflammation helps combat foreign pathogens and restores the injured tissue, while simultaneously increasing the burden of oxidative stress. This creates a vicious cycle in which smoking-related oxidative stress causes inflammation, which in turn, results in further generation of ROS, and potentially increased oxidative damage to macromolecular targets that may lead to cancer initiation and/or progression.

The Mechanism of Smoking-Induced Lung Cancer and Present Status of R Esearch on (vitamin) E Interference

Potential Micronutrients and Phytochemicals Against the Pathogenesis of Chronic Obstructive Pulmonary Disease and Lung Cancer

Recent Advances in the Methods for Smoking Cessation

Smokeless tobacco and cigarette smoking: chemical mechanisms and cancer prevention

A Review of Toxicity Mechanism Studies of Electronic Cigarettes on Respiratory System

From Tobacco Smoking to Cancer Mutational Signature: a Mediation Analysis Strategy to Explore the Role of Epigenetic Changes

Relationships among smoking, oxidative stress, inflammation, macromolecular damage, and cancer

Current perspective on e-cigarette use and respiratory outcomes: mechanisms and messaging

Smoking and Lung Cancer: Future Research Directions

Role of Free Radicals in Lung Cancer Induced by Physical and Chemical Factors

A Comparative Study of the Effects of Electronic Cigarette and Traditional Cigarette on the Pulmonary Functions of C57BL/6 Male Mice

Research Progress on Pathogenesis of Lung Cancer and Prevention Discussion

The mechanism of oxidative stress in COPD development and its application in prenvention and therapy

Role of lycopene in smoke-promoted chronic obstructive pulmonary disease and lung carcinogenesis

E-Cigarette Use: Device Market, Study Design, and Emerging Evidence of Biological Consequences

Safety Assessment Of Electronic Cigarettes And Their Relationship With Cardiovascular Disease

Health outcomes of electronic cigarettes

The role of cigarette smoke-induced epigenetic alterations in inflammation

Mechanisms of E-Cigarette Vape-Induced Epithelial Cell Damage

Fat-soluble Vitamins and Lung Cancer: Where We Are?

Toxicological Mechanisms of Carbon-Based Nanomaterials